Q2 and Q3 2019 FinancialsCanntrust's inventory and biological assets end Q12019 was estimated to yield approxiamately 17M grams of cannabis. On their Q1 statement their biological assets and inventory totalled roughly $70M+
WeedMD's outdoor grow is slated to yield approxiamately 20M grams of cannabis taking into consideration spoilage. Their Inventory and Biological assets totalled $14M end Q12019, so we can expect a similar jump to $70M+ once Q32019 financials are released.
The company is currently sitting at $180M market cap...
The only risk I see is their current cash position ($25M+ Cash, Restricted Cash and AR) and whether or not they have sufficient funds to last them until they are cash flow positive. They do have a large outstanding liability due to BMO debt financing, but their future revenues should be able to cover the interest payments relatively easy. They have one of the lowest G&As in the industry and manage their cash efficienctly. Revenues alone for Q1 were almost able to cover their G&A expenses of $3.6M last quarter. I expect to see revenue outpace their G&A expenses for Q2 2019.